Metadata

Name CCU002_01 Confirmed COVID-19 diagnoses
Type Disease or Syndrome
Group Disease or Syndrome
Data Sources





Clinical Terminologies SNOMED-CT
Codelists covid_impact_ccu00201_GDPPR_confirmed_COVID_England_SNOMEDCT.csv
Valid Event Data Range 01/01/1997 - 07/12/2020
Sex Female
Male
Authors Rochelle Knight, Venexia Walker, Samantha Ip, Jennifer A Cooper, Thomas Bolton, Spencer Keene, Rachel Denholm, Ashley Akbari, Hoda Abbasizanjani, Fatemeh Torabi, Efosa Omigie, Sam Hollings, Teri-Louise North, Renin Toms, Emanuele Di Angelantonio, Spiros Denaxas,, Johan H Thygesen, Christopher Tomlinson, Ben Bray, Craig J Smith, Mark Barber, George Davey Smith, Nishi Chaturvedi, Cathie Sudlow, William N Whiteley, Angela Wood, Jonathan A C Sterne,, CVD-COVID-UK/COVID-IMPACT consortium, Longitudinal Health and Wellbeing COVID-19 National Core Study
Agreement Date 24 Nov 2021
Version (UUID) Revision 1 (COVID-IMPACT)

Phenotypes

England primary care EHR: COVID-19 diagnosis

terminology code term code_type
SNOMEDCT 1321211000000109 Coronavirus disease 19 caused by severe acute respiratory syndrome coronavirus 2 presenting complaints simple reference set (foundation metadata concept)
SNOMEDCT 1321341000000103 Arbitrary concentration of severe acute respiratory syndrome coronavirus 2 immunoglobulin G in serum (observable entity)
SNOMEDCT 1321801000000108 Arbitrary concentration of severe acute respiratory syndrome coronavirus 2 immunoglobulin A in serum (observable entity)
SNOMEDCT 1321811000000105 Severe acute respiratory syndrome coronavirus 2 immunoglobulin A qualitative existence in specimen (observable entity)
SNOMEDCT 1240511000000106 Detection of severe acute respiratory syndrome coronavirus 2 using polymerase chain reaction technique (procedure)
SNOMEDCT 1240571000000101 Gastroenteritis caused by severe acute respiratory syndrome coronavirus 2 (disorder)
SNOMEDCT 1321241000000105 Cardiomyopathy caused by severe acute respiratory syndrome coronavirus 2 (disorder)
SNOMEDCT 1321551000000106 Severe acute respiratory syndrome coronavirus 2 immunoglobulin M detected (finding)
SNOMEDCT 1240581000000104 Severe acute respiratory syndrome coronavirus 2 ribonucleic acid detected (finding)
SNOMEDCT 1240401000000105 Antibody to severe acute respiratory syndrome coronavirus 2 (substance)
SNOMEDCT 1240391000000107 Antigen of severe acute respiratory syndrome coronavirus 2 (substance)
SNOMEDCT 1300681000000102 Assessment using coronavirus disease 19 severity scale (procedure)
SNOMEDCT 1029481000000103 Coronavirus nucleic acid detection assay (observable entity)
SNOMEDCT 1300631000000101 Coronavirus disease 19 severity score (observable entity)
SNOMEDCT 1300671000000104 Coronavirus disease 19 severity scale (assessment scale)
SNOMEDCT 121973000 Measurement of coronavirus antibody (procedure)
SNOMEDCT 120814005 Coronavirus antibody (substance)
SNOMEDCT 1240381000000105 Severe acute respiratory syndrome coronavirus 2 (organism)
SNOMEDCT 1321191000000105 Coronavirus disease 19 caused by severe acute respiratory syndrome coronavirus 2 procedures simple reference set (foundation metadata concept)
SNOMEDCT 1300721000000109 Coronavirus disease 19 caused by severe acute respiratory syndrome coronavirus 2 confirmed by laboratory test (situation)
SNOMEDCT 1240541000000107 Infection of upper respiratory tract caused by severe acute respiratory syndrome coronavirus 2 (disorder)
SNOMEDCT 1322781000000102 Severe acute respiratory syndrome coronavirus 2 antigen detection result positive (finding)
SNOMEDCT 1240751000000100 Coronavirus disease 19 caused by severe acute respiratory syndrome coronavirus 2 (disorder)
SNOMEDCT 1240561000000108 Encephalopathy caused by severe acute respiratory syndrome coronavirus 2 (disorder)
SNOMEDCT 1321541000000108 Severe acute respiratory syndrome coronavirus 2 immunoglobulin G detected (finding)
SNOMEDCT 1321181000000108 Coronavirus disease 19 caused by severe acute respiratory syndrome coronavirus 2 record extraction simple reference set (foundation metadata concept)
SNOMEDCT 1321321000000105 Severe acute respiratory syndrome coronavirus 2 immunoglobulin G qualitative existence in specimen (observable entity)
SNOMEDCT 1321761000000103 Severe acute respiratory syndrome coronavirus 2 immunoglobulin A detected (finding)
SNOMEDCT 1240411000000107 Ribonucleic acid of severe acute respiratory syndrome coronavirus 2 (substance)
SNOMEDCT 1240741000000103 Severe acute respiratory syndrome coronavirus 2 serology (observable entity)
SNOMEDCT 1008541000000105 Coronavirus ribonucleic acid detection assay (observable entity)
SNOMEDCT 186747009 Coronavirus infection (disorder)
SNOMEDCT 1321201000000107 Coronavirus disease 19 caused by severe acute respiratory syndrome coronavirus 2 health issues simple reference set (foundation metadata concept)
SNOMEDCT 1300731000000106 Coronavirus disease 19 caused by severe acute respiratory syndrome coronavirus 2 confirmed using clinical diagnostic criteria (situation)
SNOMEDCT 1321331000000107 Arbitrary concentration of severe acute respiratory syndrome coronavirus 2 total immunoglobulin in serum (observable entity)
SNOMEDCT 1321351000000100 Arbitrary concentration of severe acute respiratory syndrome coronavirus 2 immunoglobulin M in serum (observable entity)
SNOMEDCT 1321301000000101 Severe acute respiratory syndrome coronavirus 2 ribonucleic acid qualitative existence in specimen (observable entity)
SNOMEDCT 1321311000000104 Severe acute respiratory syndrome coronavirus 2 immunoglobulin M qualitative existence in specimen (observable entity)
SNOMEDCT 1322871000000109 Severe acute respiratory syndrome coronavirus 2 antibody detection result positive (finding)
SNOMEDCT 1240521000000100 Otitis media caused by severe acute respiratory syndrome coronavirus 2 (disorder)
SNOMEDCT 1240531000000103 Myocarditis caused by severe acute respiratory syndrome coronavirus 2 (disorder)
SNOMEDCT 1240551000000105 Pneumonia caused by severe acute respiratory syndrome coronavirus 2 (disorder)
SNOMEDCT 1240421000000101 Serotype severe acute respiratory syndrome coronavirus 2 (qualifier value)

Publication

Rochelle Knight, Venexia Walker, Samantha Ip, Jennifer A Cooper, Thomas Bolton, Spencer Keene, Rachel Denholm, Ashley Akbari, Hoda Abbasizanjani, Fatemeh Torabi, Efosa Omigie, Sam Hollings, Teri-Louise North, Renin Toms, Emanuele Di Angelantonio, Spiros Denaxas, Johan H Thygesen, Christopher Tomlinson, Ben Bray, Craig J Smith, Mark Barber, George Davey Smith, Nishi Chaturvedi, Cathie Sudlow, William N Whiteley, Angela Wood, Jonathan A C Sterne, for the CVD-COVID-UK/COVID-IMPACT consortium and the Longitudinal Health and Wellbeing COVID-19 National Core Study. Association of COVID-19 with arterial and venous vascular diseases: a population-wide cohort study of 48 million adults in England and Wales

medRxiv 2021.11.22.21266512; doi: https://doi.org/10.1101/2021.11.22.21266512